BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10664529)

  • 41. HLA similarities indicate shared genetic risk in 21-hydroxylase autoantibody positive South African and United States Addison's disease.
    Ross IL; Babu S; Armstrong T; Zhang L; Schatz D; Pugliese A; Eisenbarth G; Baker Ii P
    Tissue Antigens; 2014 Oct; 84(4):361-9. PubMed ID: 25040682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy.
    Laureti S; Falorni A; Volpato M; Casucci G; Picchio ML; Angeletti G; Luthman H; Brunetti P; Betterle C; Santeusanio F
    Horm Metab Res; 1996 Jul; 28(7):319-22. PubMed ID: 8858375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The natural history of autoimmune Addison's disease with a non-classical presentation: a case report and review of literature.
    Manso J; Pezzani R; Scarpa R; Gallo N; Betterle C
    Clin Chem Lab Med; 2018 May; 56(6):896-900. PubMed ID: 29478039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.
    Coco G; Dal Pra C; Presotto F; Albergoni MP; Canova C; Pedini B; Zanchetta R; Chen S; Furmaniak J; Rees Smith B; Mantero F; Betterle C
    J Clin Endocrinol Metab; 2006 May; 91(5):1637-45. PubMed ID: 16522688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gonadal function in males with autoimmune Addison's disease and autoantibodies to steroidogenic enzymes.
    Dalla Costa M; Bonanni G; Masiero S; Faggian D; Chen S; Furmaniak J; Rees Smith B; Perniola R; Radetti G; Garelli S; Chiarelli S; Albergoni MP; Plebani M; Betterle C
    Clin Exp Immunol; 2014 Jun; 176(3):373-9. PubMed ID: 24666377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease.
    Winqvist O; Karlsson FA; Kämpe O
    Lancet; 1992 Jun; 339(8809):1559-62. PubMed ID: 1351548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of autoantibodies connected to autoimmune polyendocrine syndrome type I and II and Addison's disease in girls and women with Turner syndrome.
    Stenberg AE; Sylvén L; Hedstrand H; Kämpe O; Hultcrantz M
    J Negat Results Biomed; 2007 Dec; 6():10. PubMed ID: 18088406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoimmune Addison's disease.
    Saverino S; Falorni A
    Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101379. PubMed ID: 32063488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.
    Triolo TM; Baschal EE; Armstrong TK; Toews CS; Fain PR; Rewers MJ; Yu L; Miao D; Eisenbarth GS; Gottlieb PA; Barker JM
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4517-23. PubMed ID: 19820007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dominant suppression of Addison's disease associated with HLA-B15.
    Baker PR; Baschal EE; Fain PR; Nanduri P; Triolo TM; Siebert JC; Armstrong TK; Babu SR; Rewers MJ; Gottlieb PA; Barker JM; Eisenbarth GS
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2154-62. PubMed ID: 21565792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency.
    Bratland E; Skinningsrud B; Undlien DE; Mozes E; Husebye ES
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5117-24. PubMed ID: 19890026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies against Cytochrome P450 Side-Chain Cleavage Enzyme in Dogs (Canis lupus familiaris) Affected with Hypoadrenocorticism (Addison's Disease).
    Boag AM; Christie MR; McLaughlin KA; Syme HM; Graham P; Catchpole B
    PLoS One; 2015; 10(11):e0143458. PubMed ID: 26618927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease.
    Bednarek J; Furmaniak J; Wedlock N; Kiso Y; Baumann-Antczak A; Fowler S; Krishnan H; Craft JA; Rees Smith B
    FEBS Lett; 1992 Aug; 309(1):51-5. PubMed ID: 1511745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure.
    Winqvist O; Gebre-Medhin G; Gustafsson J; Ritzén EM; Lundkvist O; Karlsson FA; Kämpe O
    J Clin Endocrinol Metab; 1995 May; 80(5):1717-23. PubMed ID: 7745025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope.
    Husebye ES; Bratland E; Bredholt G; Fridkin M; Dayan M; Mozes E
    Endocrinology; 2006 May; 147(5):2411-6. PubMed ID: 16497795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase.
    Dal Pra C; Chen S; Betterle C; Zanchetta R; McGrath V; Furmaniak J; Rees Smith B
    Eur J Endocrinol; 2004 Mar; 150(3):313-21. PubMed ID: 15012616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Peterson P; Salmi H; Hyöty H; Miettinen A; Ilonen J; Reijonen H; Knip M; Akerblom HK; Krohn K
    Clin Immunol Immunopathol; 1997 Jan; 82(1):37-42. PubMed ID: 9000040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.
    Betterle C; Dal Pra C; Mantero F; Zanchetta R
    Endocr Rev; 2002 Jun; 23(3):327-64. PubMed ID: 12050123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addison's disease: a survey on 633 patients in Padova.
    Betterle C; Scarpa R; Garelli S; Morlin L; Lazzarotto F; Presotto F; Coco G; Masiero S; Parolo A; Albergoni MP; Favero R; Barollo S; Salvà M; Basso D; Chen S; Rees Smith B; Furmaniak J; Mantero F
    Eur J Endocrinol; 2013 Dec; 169(6):773-84. PubMed ID: 24014553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population.
    Barker JM; Ide A; Hostetler C; Yu L; Miao D; Fain PR; Eisenbarth GS; Gottlieb PA
    J Clin Endocrinol Metab; 2005 Jan; 90(1):128-34. PubMed ID: 15483092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.